Device Trial Radar · NCT03934658
Remote Study of NightWare for PTSD With Nightmares
Last checked: Nov 19, 2026Latest source record: Jan 28, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
81
Actual
Start
May 21, 2019
Primary completion
Dec 15, 2021
Study completion Dec 15, 2021
Sponsor
- Lead sponsor
- NightWareNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- RationalPsych; Center for International Emergency Medical Services
- First posted
- May 2, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will provide measures of safety and efficacy of the NightWare digital therapeutic system (iPhone + Apple watch + proprietary application) for the treatment of nightmare disorder associated with post-traumatic stress disorder (PTSD)-related sleep disturbance and the impact of improved sleep with the NightWare digital therapeutic system. The investigators hypothesize that the NightWare digital therapeutic system will significantly improve sleep quality in participants with PTSD-Related nightmares and poor sleep quality.
Conditions
- PostTraumatic Stress Disorder
- Sleep Disorder
- Stress Disorder
- Sleep Initiation and Maintenance Disorders
- Combat Disorders
- Nightmares Associated With Chronic Post-Traumatic Stress Disorder
- Nightmare
- Nightmares, REM-Sleep Type
Interventions
NightWare Therapeutic SystemDevice
A wearable digital therapeutic system that will measure physiologic data when worn during sleep to deliver a mild vibration via the watch to elicit arousal thereby disrupting nightmares. This detection and stimulation sequence will be performed according to NightWare's proprietary algorithm.
NightWare Therapeutic System in Sham ModeDevice
A wearable digital therapeutic system that will measure physiologic data when worn during sleep that does not deliver interventions.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in global score on the Pittsburgh Sleep Quality Index (PSQI) from Day 0 to each subsequent 28 day evaluation periodTime frame: 0-730 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
RationalPsych
The Bronx, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.